Download presentation
Presentation is loading. Please wait.
Published byPeregrine Richard Modified over 5 years ago
1
Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy
Stephen R. Broderick, MD, MPHS, Aalok P. Patel, BS, BA, Traves D. Crabtree, MD, Jennifer M. Bell, RN, BSN, Daniel Morgansztern, MD, Clifford G. Robinson, MD, Daniel Kreisel, MD, PhD, A. Sasha Krupnick, MD, G. Alexander Patterson, MD, Bryan F. Meyers, MD, MPH, Varun Puri, MD, MSCI The Annals of Thoracic Surgery Volume 101, Issue 2, Pages (February 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Consolidated Standards of Reporting Trials diagram shows schema of study subject selection. (NSCLC = non-small cell lung cancer.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Kaplan-Meier curve comparing patients with clinical stage IIIA non-small cell lung cancer requiring pneumonectomy treated with neoadjuvant (blue line) vs adjuvant (green line) chemotherapy and radiotherapy (p = 0.74 by log-rank test). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.